H.R. 4114 · 117th Congress

Allergy Testing Access Act of 2021

Stage
In committee
Introduced
2021-06-24
Latest action
2021-06-25 · Referred to the Subcommittee on Health.

Summary

Allergy Testing Access Act of 2021

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.